Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Thoracic 3Gynecologic 2Sarcoma 1NET 1Head & Neck 1Endocrine 1Dermatologic 1Breast 1

Conditions

Melanoma 118Carcinoma, Non-Small-Cell Lung 27Skin Neoplasms 21Colorectal Neoplasms 17Lung Neoplasms 16Sarcoma 15Carcinoma, Renal Cell 15Breast Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Pancreatic Neoplasms 13Ovarian Neoplasms 13Neoplasms 13Carcinoma, Merkel Cell 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11Neoplasm Metastasis 11Head and Neck Neoplasms 11Carcinoma, Basal Cell 11Stomach Neoplasms 10Carcinoma, Hepatocellular 10Uterine Cervical Neoplasms 8Thyroid Neoplasms 8Lymphoma, T-Cell, Cutaneous 8Mycosis Fungoides 7Esophageal Neoplasms 7Brain Neoplasms 7Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma 6Gastrointestinal Neoplasms 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Neoplasms × Dermatologic × 30 days × Clear all
NCT05379985 2026-05-15

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Revolution Medicines, Inc.

Phase 1/2 Recruiting
754 enrolled
DermatologicGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplastic Processes, Pancreatic Neoplasms, Thoracic Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡